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Abstract
Introduction: Mechanical ventilation and the effect of respiratory muscle unloading on the diaphragm cause
ventilator-induced diaphragmatic dysfunction (VIDD). Atrophy of the diaphragmatic muscle is a major part of VIDD,
and has a rapid onset in most animal models. We wanted to assess the clinical evolution and risk factors for VIDD
in an adult intensive care unit (ICU) by measuring diaphragm thickness using ultrasound.
Method: We performed a single-centre observational cohort study, including 54 mechanically ventilated patients.
The right hemidiaphragm was measured daily at the zone of apposition on the midaxillary line.
Results: Mean baseline thickness was 1.9 mm (SD ± 0.4 mm), and mean nadir was 1.3 mm (SD ± 0.4 mm),
corresponding with a mean change in thickness of 32 % (95 % CI 27–37 %). Length of mechanical ventilation (MV)
was associated with the degree of atrophy, whereas other known risk factors for muscle atrophy in an ICU were
not. The largest decrease in thickness occurred during the first 72 hours of MV.
Conclusions: Diaphragm atrophy occurs quickly in mechanically ventilated patients and can accurately be
monitored using ultrasound. Length of MV, as opposed to other variables, is associated with the degree of atrophy.
Clinical trial registration: Clinicaltrials.gov NCT02299986. Registered 10/11/2014
Introduction
Muscle weakness and dysfunction are common problems
in patients hospitalized in the intensive care unit (ICU)
[1–3]. This process affects striated muscles: dysfunction
and atrophy are observed, often simultaneously, in mus-
cles of the limbs and of the diaphragm [4, 5]. Whereas
general limb muscle wasting is a more gradual and slow
process, reaching its peak after the first 2–3 weeks of ICU
stay [6, 7], diaphragmatic dysfunction appears to occur
much more rapidly [3, 8–10].
Many factors contribute to this intriguing problem in
the ICU, but mechanical ventilation (MV) by itself seems
to affect the diaphragm. The terminology ‘ventilator-in-
duced diaphragmatic dysfunction’ (VIDD), originally de-
scribed by Vassilakopoulos and Petrof, was therefore
introduced to describe these effects of mechanical ventila-
tion and respiratory muscle unloading on the diaphragm
[11, 12]. Apart from inactivity by mechanical ventilation,
other factors including inflammation, malnutrition, the
use of certain pharmacological agents, and the existence
of neuromuscular syndromes prior to ICU admission have
been reported to influence diaphragm dysfunction as well
[13]. Diaphragmatic dysfunction refers to altered force
and structure, and both can be studied [6, 14, 15].
The complex disease process of VIDD represents more
than atrophy alone. The dysfunction itself originates at the
level of the muscle cell membrane and/or the contractile
apparatus, rather than that of the axonal phrenic nerve or
the neuromuscular junction [5, 16]. Diaphragmatic muscle
thinning is an essential part of VIDD [6, 12].
Functional loss (i.e. the decrease in the diaphragm’s con-
tribution in generating a breath) can be calculated by the
Gilbert index [8, 13]. In addition to exploring the loss of
contractility, imaging techniques have been used to
visualize the excursion and anatomy of the diaphragm.
Ultrasonography is becoming increasingly popular in the
day-to-day management of ICU patients [6, 11, 14, 15]. It
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is a simple, non-invasive and safe imaging technique that
can be used for the assessment of distinctive diaphrag-
matic characteristics [17]. These include movement pa-
rameters such as amplitude and velocity of contraction,
which can be assessed using M-mode ultrasound [18]. In
addition, static and dynamic (thickening fraction during
inspiration) diaphragmatic thickness can also be measured
by ultrasonography [19].
In a small cohort (n = 7) of mechanically ventilated
patients, Grosu and colleagues originally demonstrated
that the thickness of the diaphragm decreases about 6 %
per day [9]. Others have reconfirmed the feasibility of
diaphragm thickness recording in ventilated patients
[20]. Good reproducibility and repeatability of right
hemidiaphragm thickness measurements was demon-
strated. Diaphragm thickening, defined as recording the
difference between inspiration and expiration in B- or
M-mode, could serve as a novel parameter to predict
weaning and extubation success [21, 22]. To study both
the extent and the time-course of diaphragmatic atro-
phy, we longitudinally measured end-expiratory dia-
phragm thickness in a cohort of mechanically ventilated
ICU patients.
Methods
This longitudinal, single-centre, observational cohort
study was approved by the institutional review board and
ethics committee of the Antwerp University Hospital,
Antwerp, Belgium (study identifier: 13/06/70), and was
registered at Clinicaltrials.gov (NCT02299986). All sub-
jects’ healthcare proxy provided written informed consent.
The study was performed in accordance with the ethical
standards of the Declaration of Helsinki. Written in-
formed consent was obtained to publish Fig. 1a and b.
Subjects and data recording
Between May 2013 and June 2015, patients admitted to
the intensive care unit (ICU) were evaluated for enrol-
ment into the study. In 56 newly intubated patients, base-
line thickness measurements were made within 24 hours
after the start of mechanical ventilation (MV). Selection of
patients was based on the likelihood of prolonged (>72 h)
MV. Exclusion criteria were age <18 years, history of
neuromuscular disease or known anatomical malforma-
tion of the diaphragm, use of non-invasive ventilation be-
fore the start of MV, hemodynamic instability, the
presence of a tracheostomy and an admission to an ICU
within 12 months prior to this inclusion.
The first ultrasonographic measurement was performed
within 24 hours after the start of MV, and the subsequent
recordings were acquired daily within a 24 hours ± 4 hours
time frame. The same investigator (TS, ICU physician)
performed all the recordings. A board-certified radiologist
experienced in ultrasonography visually inspected the B-
mode still images of the diaphragm and the position of
the ‘caliper’ markers as recorded by TS. Recordings were
discontinued at the moment of unassisted spontaneous
ventilation, tracheostomy, extubation, or when a patient
died. Primary outcome parameter was the change in dia-
phragm thickness from baseline to nadir.
Demographic variables, including the Simplified Acute
Physiology Score II (SAPS II) [23], were extracted from
the digital patient data management system (Metavision,
iMDsoft, Tel Aviv, Israel). Secondary outcome parame-
ters were patient characteristics associated with a de-
crease in diaphragm thickness: age, sex, SAPS II,
duration of MV, percentage of time in controlled MV
modes, use of corticosteroids during ICU stay, sepsis,
continued use of neuromuscular blocking agents and
aminoglycosides antibiotic use as possible associated risk
factors, as they are known risk factors for ICU-acquired
weakness [10, 14, 24–26]. All patients were sedated in
accordance with our sedation protocol. Briefly, patients
were sedated with propofol plus remifentanil drips, ti-
trated to a Richmond Agitation-Sedation Scale set by the
treating ICU physician. If these drugs were insufficient
in sedating the patient adequately, midazolam could be
added. Neuromuscular blocking agents usage is left to
the discretion of the treating ICU physician, and was
never routinely administered in our patients.
Measurement technique
Diaphragm thickness was measured ultrasonographi-
cally, using a standardized technique at the zone of ap-
position on the midaxillary line. This was first described
in 1997 by Cohn et al., and since then applied by others
[9, 20, 27, 28]. As in the study by Goligher et al. [20], it
proved difficult to consistently visualize the left hemi-
diaphragm, so measurements of left hemidiaphragm
thickness were not performed in this study. We recorded
the type of applied ventilation mode hourly, as this may
have its effect on the evolution of diaphragm thickness,
and included the amount of time in controlled ventila-
tion modes as a possible predictor for diaphragm
atrophy. More details about the measurement technique
and the recorded ventilator parameters are noted in
Additional file 1.
Before commencing the study, both intra- and inter-
observer variability of diaphragm ultrasound recordings
in both ventilated patients and non-ventilated volunteers
on different time points were performed, by TS and
with a board-certified radiologist experienced in ultra-
sonography (BC). The coefficients of reproducibility
(Guttman) for inter-observer variability for TS were
0.875 for the volunteers study and 0.971 for the venti-
lated patients study. The coefficients of reproducibility
for intra-observer variability for TS were 0.899 for the
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volunteers study and 0.945 for the ventilated patients
study.
Statistics
Statistical analyses were performed with SPSS Statistics
software, version 20.0 for Mac (IBM Corp., Armonk,
NY, USA) Results were reported as mean ± standard de-
viation (SD) or median (interquartile range (IQR)). The
relationships between patient characteristics (including
the risk factors) and diaphragm thickness changes were
assessed using the Mann-Whitney U test and linear
regression models. Changes in baseline and nadir dia-
phragm thickness were analysed using the Wilcoxon
signed-rank test. All analysed risk factors for atrophy
were entered in a multivariate regression model. The
level of statistical significance was set at 0.05. The statis-
tical methods are explained in detail in Additional file 1.
Results
General characteristics
Fifty-six mechanically ventilated patients were enrolled,
of which 54 patients were ventilated for at least 72 hours
and thus provided sufficient data to be analysed. In all
analysed patients the right hemidiaphragm was mea-
sured. One patient who had a chest drain inserted in the
right pleural space was excluded for further analysis
Fig. 1 Ultrasound sample images. Right hemidiaphragm thickness recording image after admission (a) and on day 5 (b) as obtained during
the study
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because no reliable measurements could be performed
on the right hemidiaphragm, totalling the number of
subjects that could be analysed to 53. We were able to
successfully record the diaphragm thickness in 100 % of
the attempts for all patients, with a total of 308 mea-
surements. The maximal change in diaphragm thickness
(from baseline to nadir) was calculated for each patient.
Clinical characteristics of the included patients are shown
in Table 1. Median SAPS II score was 72 (IQR 63–80).
Median time on the ventilator was 8 days (IQR 4–14 days).
The first measurement was performed within 24 hours
after initiation of ventilation (mean 13 h and 08 min, SD
7 h 50 min). In total, 14 patients received continuous
muscle relaxant administration (cisatracurium) at any
given moment while receiving MV. Furthermore, 35 pa-
tients in total received one or more bolus administrations
of a muscle relaxant (either rocuronium of cisatracurium).
Diaphragmatic thickness in ventilated patients over time
Mean baseline thickness was 1.9 mm (SD± 0.4 mm). Com-
pared to baseline thickness, the last recorded diaphragm
thickness before the moment of ventilator liberation,
tracheotomy, death, or end of assisted ventilation in the
intubated (brain) dead patient was decreased by more than
10 % in the vast majority of subjects (n = 40, 77 %),
remained stable in ten (19 %) and increased by more than
10 % in two (4 %) subjects. The rate of diaphragm thickness
decline was 10.9 % per day on average (SD 10.2 %).
Mean nadir was 1.3 mm (SD ± 0.4 mm), corresponding
with a mean maximal decrease in thickness of 32 % (95 %
CI 27–37 %) for all patients combined. After 24 hours of
ventilation, we already see a drop of diaphragm thickness
of 9 % (mean thickness 1.7 mm, SD ± 0.5 mm, P = 0.008
versus baseline). After 48 and 72 hours of ventilation, dia-
phragm thickness decreases with respectively 20 % (mean
thickness 1.5 mm, SD ± 0.4 mm) and 26 % (mean thick-
ness 1.4 mm, SD ± 0.4 mm) versus baseline recordings, il-
lustrating the rapid progression of the atrophy in VIDD.
Median time to nadir was 3 days (IQR 2–7 days). The
change in thickness after 72 hours did not correlate with
the time spent on the ventilator afterwards. Fig. 2 shows
all diaphragm thickness recordings over time for all in-
cluded patients. Fig. 3 shows the mean thickness of the
diaphragm from baseline to day 5.
Risk factors associated with diaphragm thinning
Length of ventilation was associated with diaphragm thin-
ning (F = 4.7, P = 0.034). Mean time in controlled ventila-
tion modes was 58 % (SD 28 %). Mean time spent in
controlled ventilation modes from start of MV to nadir was
77 % (SD 42 %). Age, gender, disease severity (SAPS II) on
admission, steroid use during ICU stay, the administration
of single or continued doses of muscle relaxants, or sepsis
on admission were not associated with maximal decrease in
diaphragm thickness. The overall time in assisted versus
controlled ventilation modes was not associated with the
degree of atrophy, and neither was the time in assisted ver-
sus controlled ventilation modes from start of MV to nadir.
The percentage of time in controlled MV, sepsis status,
corticosteroids administration and aminoglycoside adminis-
tration parameters were entered in a multivariate regression
model, but none of these parameters reached significance
(full results in Additional file 1). A subgroup analysis was
performed for the sepsis patients who were diagnosed with
sepsis upon admission. Mean change in thickness was not
faster in the sepsis group compared to the non-sepsis
group, when considering decrease in thickness 24, 48 or
72 hours after the start of MV.
Discussion
In this study, we report a longitudinal follow-up of dia-
phragm thickness in a number of mechanically venti-
lated patients in the ICU. We demonstrate a rapid
progression of diaphragm atrophy, with already a signifi-
cant decrease in thickness after just 1 day of MV, and
the largest decrease in diaphragm thickness occurring
Table 1 Patient characteristics and outcome parameters
Age (median, IQR) 67 (55-75)
Male/female 33/20
SAPS II (median, IQR) 72 (63-80)
ICU mortality (n, %) 20 (38)
Maximal change in thickness
(mean %, 95 % CI)
32 (27-37)
Aminoglycoside (AG) use (n, %) 15 (28)
Maximal change in thickness
in AG subgroup (mean %, SD)
38 (18)
Maximal change in thickness
in non-AG subgroup (mean %, SD)
30 (18)
P 0.367
Corticosteroids (CS) use (n, %) 26 (49)
Maximal change in thickness
in CS subgroup (mean %, SD)
34 (17)
Maximal change in thickness in




agents administration (n, %)
14 (28)
Single dose or more of neuromuscular
blocking agents administration (n, %)
35 (66)
Sepsis on admission (n, %) 25 (47)
Maximal change in thickness in sepsis
subgroup (%, SD)
35 (28-42)
Sepsis during ICU stay (n, %) 45 (85)
IQR interquartile range, SAPS II Simplified Acute Physiology Score II, ICU
intensive care unit, CI confidence interval, SD standard deviation
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during the first 72 hours of MV. The degree of atrophy
in our cohort is associated with the length of ventilation,
but not with other known risk factors for muscle atro-
phy, including sepsis or corticosteroid use.
Diaphragm muscle atrophy in ventilated patients was
previously demonstrated in humans: as demonstrated in
muscle biopsies in brain-dead organ donors [3, 6]: Jaber
and co-workers found a 39 % difference in mean cross-
sectional area between short- (<6 h) and long-term ven-
tilated patients [3], and the difference was even greater
in the study by Levine et al., with a difference of 57 %
and 53 % in cross-sectional areas of slow-twitch and
fast-twitch fibres respectively versus biopsies in short-
term (2–3 h) ventilated patients [6]. Furthermore, in this
study, as little as 18 hours of controlled MV resulted in
noticeable atrophy of diaphragm muscle fibres. Biopsy,
as a way of evaluating atrophy is hindered by the impos-
sibility to make repeated measures, and thus unavoidably
comparing the thickness in two different groups.
In our study, the thickness of the diaphragm was mea-
sured by a validated ultrasound technique [27, 28].
Grosu and co-workers were the first to report the use of
repeated ultrasound recordings in seven ventilated
patients to assess diaphragm atrophy [9]: a 6 % decrease
in diaphragm thickness per day of MV was shown. Our
study shows a comparable result, with a decrease of 9 %
after one day of MV, and a total decrease of 21 % and
26 % after 2 or 3 days of MV respectively. These findings
illustrate that diaphragm atrophy is a rapidly evolving
process, with an exponential decline in thickness.
A logarithmic relationship between length of ventilation
and diaphragmatic strength was already demonstrated by
Hermans et al. using twitch transdiaphragmatic diaphrag-
matic pressure generation recordings [14]. Jaber et al. per-
formed a similar investigation and demonstrated a mean
decrease of 32 % in diaphragm force in long-term venti-
lated patients [3]. Furthermore, they were able to associate
diaphragm atrophy with a decrease in twitch transdiaph-
ragmatic diaphragmatic pressure generation. Although the
results are interesting, technical difficulties are likely to
preclude this technology from being an easy-to-use bed-
side tool for longitudinal diaphragm function follow-up.
In septic ICU patients, atrophy is more pronounced in
the diaphragm compared to limb muscle [29]. In our co-
hort, we could not associate diaphragm atrophy with
sepsis [30], but this does not exclude that inflammation
may have had effects on contractile dysfunction without
associated additional atrophy, which we did not meas-
ure. The ultrastructural injury may be more pronounced
in the sepsis subgroup, and thereby resulting in poten-
tially more pronounced degrees of VIDD [10].
Inactivity of the diaphragm is present in patients that
are on partially assisted or controlled mechanical venti-
lation [20]. In our cohort, the diaphragm muscle atrophy
was heterogeneously present, and could not be directly
associated with the amount of time the patient was
Fig. 2 Diaphragm thickness measurements. Raw values of all diaphragm thickness recordings in millimetres for each day of mechanical
ventilation. Lines use a Bézier curve construction (see Additional file 1)
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ventilated in a controlled or assisted mode of ventilation.
There is, however, no guarantee that a diaphragm is
active during assisted modes of ventilation, for patients
can trigger the ventilator using secondary respiratory
muscles [31]. Interestingly, in the study by Hermans et al.,
longer periods of support ventilation or bi-level positive-
pressure ventilation were also linked to increased dia-
phragm dysfunction [14]. Furthermore, rats exposed to
controlled MV or breathing spontaneously during propofol
sedation for 24 hours had a similar degree of diaphragm at-
rophy, suggesting that diaphragm activity may not always
be protective for VIDD [32]. Whether maintaining dia-
phragm activity during MV is protective for VIDD or atro-
phy in humans remains to be answered [33]. Diaphragm
pacing was successfully tested as a preventive strategy in
ventilated sheep [34], and intermittent spontaneous breath-
ing has been reported as a protective strategy in a rat model
[35]. It does seem to be a plausible solution, because mech-
anical inactivity of muscles leads to an oversupply of react-
ive oxygen species (ROS) in dysfunctional mitochondria,
triggering the VIDD cascade [36].
Our findings are in accordance with the data described
in a very recent manuscript by Goligher and co-workers
[37]. Diaphragm thickness and contractile activity (quan-
tified by the inspiratory thickening fraction) in their
group of ventilated patients decreased by 10 % or more
in 44 % of all cases, remained unchanged in 44 %, and
even increased by more than 10 % in a minority (12 %).
In our study group, diaphragm thickness decreased more
than it did in Goligher’s cohort. Diaphragm thickness
decreased by more than 10 % in 40 subjects (77 %),
remained stable in ten (19 %) and increased by more
than 10 % in two (4 %) subjects. It would be interesting
to know the exact relationship between the evolution of
Fig. 3 Diaphragm thickness measurements. Mean thickness of the diaphragm with 95 % CI as recorded with ultrasound from baseline recordings
(day 0) to 5 days after baseline
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diaphragmatic thickness and the duration of weaning or
weaning effort. Unfortunately, as our ICU habits and
protocol allow great variability of weaning strategies
between subjects we could not really explore the rela-
tionship as the exact time when weaning ‘started’ cannot
be taken into account. As the recent data in Goligher’s
study [37] showed that contractile activity of the dia-
phragm decreased with increasing ventilator driving
pressure (P = 0.01) and controlled ventilator modes
(P = 0.02), one might assume that titrating ventila-
tory support to maintain normal levels of inspiratory
effort may prevent changes in diaphragm configur-
ation associated with mechanical ventilation. For the
time being, awaiting results from newer studies tak-
ing the weaning process into account, we can only
hypothesize that diaphragm thinning is a feature of
diaphragm dysfunction with associated worse clinical
respiratory outcome.
Other therapeutic strategies, apart from the possibil-
ity of continued activity, remain to be explored as
well. Regretfully, up to now, we do not have a clear
treatment plan for patients with VIDD available.
Further trials are necessary to determine whether MV
can evolve from lung protective towards a muscle
protective MV. Given the quick onset of VIDD in
ventilated patients, it seems prudent to assume that
muscle protection may be needed as early as possible. The
diaphragm appears to be exceptionally susceptible for
disuse atrophy, more so than limb muscles, and even
more when sepsis is present [29].
Unavoidably, our study has several limitations. We
measured a morphological characteristic, and atrophy is
not necessarily linked with muscle strength. In this
study, we only evaluated thickness and not diaphragm
function or strength.
However, data demonstrate the association between
atrophy and muscle strength in VIDD [3]. A second
limitation is that inflammation and lipid overload may
cause swelling of muscle cells, and affect thickness
recordings [36]. A third limitation is that we do not
have a real baseline thickness recording for our pa-
tients. All baseline thickness measurements were per-
formed after the start of mechanical ventilation, albeit
within a few hours after the initiation. Whether
decline of diaphragmatic thickness occurs in ICU pa-
tients regardless of mechanical ventilator support
needs to be determined too.
Conclusions
This study describes the day-by-day evolution of dia-
phragm atrophy in VIDD in ICU patients, measured by
ultrasonography. Mean baseline thickness was 1.9 mm
and mean nadir was 1.3 mm corresponding with a mean
change in thickness of 32 %. Length of MV, as opposed
to other known risk factors for muscle atrophy, was
associated with the degree of diaphragm atrophy. The
diaphragm atrophy occurred fast, with the largest de-
crease in thickness occurring during the first 72 hours of
MV. Further research is needed to determine whether
MV can evolve from lung protective towards a muscle
protective MV.
Key messages
 Diaphragm atrophy in ventilated patients occurs
fast
 Diaphragm thickness can be monitored using
ultrasound to assess the daily evolution and the
effect of different ventilation strategies
 Strategies to prevent diaphragm muscle loss should
be applied early in the course of mechanical
ventilation
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